"Indian pharma is globally competitive and forwardlooking in technology, policy and industrial strategy"

From policy frameworks to addressing industry challenges and positioning, the Department of Pharmaceuticals (DoP), Government of India forthcoming initiatives to overhaul the pharma industry, are paving the way towards global pharmaceutical dominance. Dr Arunish Chawla, Secretary, Department of Pharmaceuticals (DoP), Government of India in an exclusive interview with BioSpectrum, shares insights into the comprehensive strategy aimed at reshaping India's pharmaceutical landscape, propelling the nation to the forefront in the global arena. 

- 

Please provide an overview of the strategic move to reform and redesign the Scheme for Strengthening the Pharmaceutical Industry.

We are charting out a comprehensive strategy to reform and redesign the existing Scheme for Strengthening the Pharmaceutical Industry. This initiative is about enhancing our infrastructure facilities and positioning India as a leader in the pharmaceutical domain.

What's the framework of the revamped scheme and its key sub-schemes?